We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIXP icon
4726
AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF
SIXP
$43.8M
$37.5K ﹤0.01%
1,218
-3,806
-76% -$114K
CINT icon
4727
CI&T Inc
CINT
$423M
$37.2K ﹤0.01%
7,228
SLN
4728
Silence Therapeutics
SLN
$546M
$37K ﹤0.01%
7,136
+101
+1% +$561
PMI
4729
Picard Medical
PMI
$37K ﹤0.01%
+4,357
New +$30.7K
ALTO icon
4730
Alto Ingredients
ALTO
$338M
$37K ﹤0.01%
34,253
NDLS icon
4731
Noodles & Co
NDLS
$95.1M
$37K ﹤0.01%
7,271
SYK icon
4732
CALL
Stryker
SYK
$135B
$37K ﹤0.01%
+100
New +$38.6K
FLYX icon
4733
flyExclusive
FLYX
$63.2M
$36.8K ﹤0.01%
+7,457
New +$25.5K
AMRN
4734
Amarin Corp
AMRN
$297M
$36.7K ﹤0.01%
2,242
+194
+9% +$3.01K
ARTV
4735
Artiva Biotherapeutics
ARTV
$487M
$36.4K ﹤0.01%
12,696
+10,790
+566% +$28.9K
ACRV icon
4736
Acrivon Therapeutics
ACRV
$61.2M
$36.1K ﹤0.01%
19,965
-960
-5% -$1.35K
GPRK icon
4737
GeoPark
GPRK
$609M
$36K ﹤0.01%
5,649
+906
+19% +$5.97K
ESEA icon
4738
Euroseas
ESEA
$536M
$35.8K ﹤0.01%
600
-125
-17% -$7.04K
CRESY
4739
Cresud
CRESY
$806M
$35.6K ﹤0.01%
3,899
XT icon
4740
iShares Future Exponential Technologies ETF
XT
$3.7B
$35.4K ﹤0.01%
492
VYM icon
4741
Vanguard High Dividend Yield ETF
VYM
$80.8B
$35K ﹤0.01%
248
ORMP icon
4742
Oramed Pharmaceuticals
ORMP
$162M
$34.8K ﹤0.01%
13,198
TCRX icon
4743
TScan Therapeutics
TCRX
$48.5M
$34.7K ﹤0.01%
19,077
-2,101
-10% -$3.72K
SBC
4744
SBC Medical Group
SBC
$318M
$34.5K ﹤0.01%
7,948
-1,638
-17% -$7.39K
CRBN icon
4745
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
$34.5K ﹤0.01%
152
SII
4746
Sprott
SII
$2.68B
$34.4K ﹤0.01%
414
-4,103
-91% -$286K
HYMC icon
4747
Hycroft Mining Holding Corp
HYMC
$1.79B
$33.6K ﹤0.01%
+5,417
New +$24.1K
AMX icon
4748
America Movil
AMX
$74.6B
$33.6K ﹤0.01%
1,598
+792
+98% +$15.1K
HEWJ icon
4749
iShares Currency Hedged MSCI Japan ETF
HEWJ
$713M
$33.5K ﹤0.01%
681
LOMA
4750
Loma Negra
LOMA
$1.34B
$33.5K ﹤0.01%
+4,545
New +$45.2K

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.